17356-19-3 Usage
Description
1-Ethynylcyclopentanol is an organic compound characterized by a cyclopentane ring with an ethynyl group attached to the first carbon atom and a hydroxyl group attached to the same carbon. It is a clear colorless to yellow liquid after melting and is used in various applications in the field of organic synthesis.
Uses
Used in Organic Synthesis:
1-Ethynylcyclopentanol is used as a building block for the synthesis of various organic compounds. Its unique structure allows it to be a versatile intermediate in the preparation of pharmaceuticals, agrochemicals, and other specialty chemicals. The ethynyl group can be further functionalized through reactions such as hydrolysis, reduction, or coupling, enabling the creation of a wide range of molecules with diverse properties and applications.
Used in Pharmaceutical Industry:
1-Ethynylcyclopentanol is used as a key intermediate in the synthesis of pharmaceutical compounds. Its unique structure allows for the development of new drugs with improved efficacy and selectivity. The ethynyl group can be modified to introduce various functional groups, which can enhance the drug's pharmacokinetic and pharmacodynamic properties.
Used in Agrochemical Industry:
1-Ethynylcyclopentanol is used as a starting material for the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure can be tailored to create molecules with specific modes of action, leading to the development of more effective and environmentally friendly agrochemicals.
Used in Specialty Chemicals:
1-Ethynylcyclopentanol is used in the production of specialty chemicals, such as fragrances, dyes, and polymers. Its unique structure allows for the creation of novel compounds with specific properties, making it a valuable resource in the development of new materials and products.
Synthesis Reference(s)
Synthetic Communications, 18, p. 131, 1988 DOI: 10.1080/00397918808077336
Check Digit Verification of cas no
The CAS Registry Mumber 17356-19-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,3,5 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 17356-19:
(7*1)+(6*7)+(5*3)+(4*5)+(3*6)+(2*1)+(1*9)=113
113 % 10 = 3
So 17356-19-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H10O/c1-2-7(8)5-3-4-6-7/h1,8H,3-6H2
17356-19-3Relevant articles and documents
Halogen-Substituted Allenyl Ketones through Ring Opening of Nonstrained Cycloalkanols
Wu, Penglin,Ma, Shengming
supporting information, p. 2533 - 2537 (2021/04/13)
An efficient synthesis of halogen-substituted allenyl ketones via Ag-catalyzed oxidative ring opening of allenyl cyclic alcohols under mild reaction conditions has been achieved. The reaction features a wide substrate scope and excellent regioselectivity. The synthetic potential of the products has been demonstrated by their conversion to stereodefined alkenes and heterocyclic compounds.
ETHERS AND ESTERS OF 1-SUBSTITUTED CYCLOALKANOLS FOR USE AS AROMA CHEMICALS
-
Page/Page column 55, (2020/05/21)
The present invention relates to the use of an ether or an ester of a 1 -substituted cycloalkanol or of mixtures of two or more ethers or esters of 1 -substituted cycloalkanols or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof as aroma chemicals; to the use thereof for modifying the scent character of a fragranced composition; to an aroma chemical composition containing an ether or an ester of a 1 -substituted cycloalkanol or of mixtures of two or more ethers or esters of 1 -substituted cycloalkanols or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof; and to a method of preparing a fragranced composition or for modifying the scent character of a fragranced composition. The invention further relates to specific ethers or esters of 1 -substituted cycloalkanols.
Opioid receptor agonists and application thereof
-
, (2019/01/24)
The invention discloses compounds and salts thereof that can be used as opioid receptor ligands, a preparation method of the compounds, compositions containing the compounds, and a use of the compounds as [mu] opioid receptor agonists; the compounds are used for treatment of [mu] opioid receptor-mediated related diseases, such as pains and pain-related disorders.
